Showing results (1-10 of 139) with videos related to

Sort By:
Pageof 14
Current Pharmaceutical Design|September 29, 2012
Future of protease activity assaysMagdalena Wysocka, Adam Lesner
Current Pharmaceutical Design|December 30, 2011
Sunflower trypsin inhibitor 1 as a molecular scaffold for drug discoveryAdam Lesner, Anna Łęgowska, Magdalena Wysocka, et al.
Analytical Biochemistry|October 2, 2023
Optimization of fluorescent substrates for ADAM17 and their utility in the detection of diabetesHonorata Sikora, Natalia Gruba, Magdalena Wysocka, et al.
Combinatorial Chemistry & High Throughput Screening|March 10, 2007
Selection of new chromogenic substrates of serine proteinases using combinatorial chemistry methodsMagdalena Wysocka, Bozena Kwiatkowska, Marek Rzadkiewicz, et al.
Protein and Peptide Letters|June 8, 2012
Pegylated fluorescent peptides as substrates of proteolytic enzymesMagdalena Wysocka, Adam Lesner, Jadwiga Popow, et al.
Bioorganic & Medicinal Chemistry|April 14, 2009
Introduction of non-natural amino acid residues into the substrate-specific P1 position of trypsin inhibitor SFTI-1 yields potent chymotrypsin and cathepsin G inhibitorsAnna Łegowska, Dawid Debowski, Adam Lesner, et al.
Protein and Peptide Letters|April 10, 2009
Low-molecular-weight aldehyde inhibitors of cathepsin GAdam Lesner, Magdalena Wysocka, Marta Solek, et al.
Molecular Diversity|April 10, 2009
Selection of peptomeric inhibitors of bovine alpha-chymotrypsin and cathepsin G based on trypsin inhibitor SFTI-1 using a combinatorial chemistry approachAnna Łegowska, Dawid Debowski, Adam Lesner, et al.
Analytical Biochemistry|August 26, 2014
Ultrasensitive internally quenched substrates of human cathepsin LMonika Lęgowska, Magdalena Wysocka, Timo Burster, et al.
Molecules (Basel, Switzerland)|April 26, 2025
Lipidated DAPEG Polymers as a Non-Toxic Transfection Agent-Influence of Fatty Acid Side Chain on Transfection EfficacyWiktoria Mallek, Anita Romanowska, Wiktoria Machowicz, et al.
Pageof 14